Lundergan C F, Reiner J S, McCarthy W F, Coyne K S, Califf R M, Ross A M
Cardiovascular Research Institute and the GUSTO-I Core Angiographic Laboratory, The George Washington University, Washington, DC, USA.
J Am Coll Cardiol. 1998 Sep;32(3):641-7. doi: 10.1016/s0735-1097(98)00278-2.
The purpose of this study was to determine patient characteristics that are a priori predictors of early infarct related artery patency following thrombolytic therapy, and to provide a paradigm which may identify patients who would be most likely to achieve restoration of normal (TIMI 3) coronary flow in response to thrombolytic therapy.
Restoration of infarct-related artery perfusion in acute myocardial infarction is necessary for preservation of ventricular function and mortality reduction. Clinical variables that are a priori predictors of early patency with currently available thrombolytic regimens have not been fully characterized.
The probability of early infarct-related artery patency (TIMI 3 flow) was determined by multivariable logistic regression. We determined a reduced (parsimonious) model for predicting early (90 min) infarct-related artery patency (TIMI grade 3) based on data from 1,030 patients in the GUSTO-I Angiographic study.
Predictors of 90 min TIMI 3 flow are use of an accelerated t-PA regimen (vs. streptokinase containing regimens) (chi2=39.1; p < or = 0.0001), infarct related artery (RCA/Lcx vs. LAD) (chi2=12.7; p=0.0004), body weight (chi2=10.3; p=0.001) and history of smoking (chi2=7.4; p=0.007). Time from symptom onset to treatment was not significant (p=0.71).
The efficacy of currently available thrombolytic regimens is chiefly dependent on choice of thrombolytic regimen, body weight, infarct-related coronary artery and smoking history. Clinical variables alone correctly predict a priori TIMI 3 flow in the infarct-related artery 64% of the time. Patients with body weights greater than 85 kg are at a significant disadvantage with regard to achieving successful thrombolysis compared to those with lesser body weights.
本研究的目的是确定哪些患者特征是溶栓治疗后早期梗死相关动脉通畅的先验预测因素,并提供一种模式,用于识别最有可能通过溶栓治疗实现正常(TIMI 3级)冠状动脉血流恢复的患者。
急性心肌梗死中梗死相关动脉灌注的恢复对于维持心室功能和降低死亡率至关重要。目前可用溶栓方案早期通畅的先验预测临床变量尚未完全明确。
通过多变量逻辑回归确定早期梗死相关动脉通畅(TIMI 3级血流)的概率。我们基于GUSTO-I血管造影研究中1030例患者的数据,确定了一个简化(简约)模型,用于预测早期(90分钟)梗死相关动脉通畅(TIMI 3级)。
90分钟TIMI 3级血流的预测因素包括使用加速t-PA方案(与含链激酶方案相比)(χ2=39.1;p≤0.0001)、梗死相关动脉(RCA/Lcx与LAD相比)(χ2=12.7;p=0.0004)、体重(χ2=10.3;p=0.001)和吸烟史(χ2=7.4;p=0.007)。症状发作至治疗的时间无显著意义(p=0.71)。
目前可用溶栓方案的疗效主要取决于溶栓方案的选择、体重、梗死相关冠状动脉和吸烟史。仅临床变量能正确预测梗死相关动脉先验TIMI 3级血流的时间为64%。与体重较轻的患者相比,体重超过85 kg的患者在实现成功溶栓方面处于显著劣势。